We are live on ! Find out more
AEMD icon

Aethlon Medical

18 hedge funds and large institutions have $1.43M invested in Aethlon Medical in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 2

75% more capital invested

Capital invested by funds: $816K → $1.43M (+$611K)

50% more funds holding

Funds holding: 1218 (+6)

0% more ownership

Funds ownership: 0%0.01% (+0%)

Holders
18
Holders Change
+6
Holders Change %
+50%
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
2
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

AEMD Hedge Fund Activity: Q1 2021 in Review

18 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q1 2021, worth a combined $1.43M — up 75% from $816K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new AEMD positions and 2 closed out — a net gain of 6 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $737K. The largest seller was Schonfeld Strategic Advisors, exiting entirely with an estimated $41K sold.

  • 18 institutional investors held Aethlon Medical (AEMD) as of Q1 2021, up from 12 in Q4 2020.
  • Funds reported $1.43M of Aethlon Medical stock for Q1 2021, up 75% quarter-over-quarter.
  • 8 funds opened new Aethlon Medical positions in Q1 2021 and 2 closed out, a net change of +6 holders.
  • The largest Aethlon Medical buyer in Q1 2021 was Renaissance Technologies, an estimated $737K added.
  • The largest Aethlon Medical seller in Q1 2021 was Schonfeld Strategic Advisors, an estimated $41K sold.

Based on aggregated 13F filings for Q1 2021.